Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oxidative phosphorylation (OXPHOS) system, often referred to as the mitochondrial energy metabolism machinery, is the primary site of cellular adenosine triphosphate (ATP) production in eukaryotic cells (StatPearls, 2023). It is composed of five multi-subunit enzyme complexes (Complexes I-V) and two mobile electron carriers (ubiquinone and cytochrome c) embedded within the inner mitochondrial membrane (UniProt, 2024). This machinery couples the transfer of electrons from nutrient-derived donors to molecular oxygen with the pumping of protons to create an electrochemical gradient used by ATP synthase to generate energy (Nature, 2021). Beyond bioenergetics, it is a critical regulator of cellular redox state, reactive oxygen species (ROS) production, and the intrinsic pathway of apoptosis (Nature Reviews Molecular Cell Biology, 2020). Dysfunctions in this system are central to the pathogenesis of primary mitochondrial diseases, neurodegenerative disorders like Parkinson's disease, and metabolic syndromes (PubMed, 2022). In oncology, many tumors exhibit a dependency on OXPHOS for survival and metastasis, leading to the development of drugs like IACS-010759 and atovaquone that target specific respiratory complexes (Nature Reviews Cancer, 2020). Furthermore, drugs like metformin are known to exert some of their metabolic effects through the inhibition of Complex I (Journal of Clinical Investigation, 2013). However, the essential role of mitochondrial respiration in vital organs such as the heart and brain presents a significant challenge for drug safety, often manifesting as lactic acidosis or systemic toxicity (Toxicological Sciences, 2019).
Inhibition of mitochondrial respiratory chain complexes (I-IV) or ATP synthase (Complex V) to disrupt ATP production, modulate redox balance, and induce metabolic stress.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative phosphorylation system (OXPHOS) (OXPHOS).